17β-Benzoyloxy-androsta-1,4-dien-3-one
CAS: 19041-66-8
Ref. 3D-UAA04166
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- (17β)-17-(Benzoyloxy)androsta-1,4-dien-3-one
- 17beta-Hydroxyandrosta-1,4-dien-3-one benzoate
- 3-Oxoandrosta-1,4-Dien-17-Yl Benzoate
- Androsta-1,4-dien-3-one, 17-(benzoyloxy)-, (17β)-
- Androsta-1,4-dien-3-one, 17β-hydroxy-, benzoate
- Androstadienolone benzoate
- Boldenone benzoate
17β-Benzoyloxy-androsta-1,4-dien-3-one is an analog of androstenedione that has been shown to have anticancer properties. This compound inhibits protein kinases involved in cell cycle regulation, such as cyclin-dependent kinase (CDK) 2 and CDK4, leading to apoptosis in cancer cells. It has been tested on human cancer cell lines and shown to be effective against several types of tumors, including breast, prostate, and lung cancers. Additionally, this compound has been found in the urine of Chinese individuals and may have potential as a diagnostic marker for certain types of cancer. As an inhibitor of CDKs, 17β-Benzoyloxy-androsta-1,4-dien-3-one represents a promising new class of anticancer drugs with potential therapeutic applications.
Chemical properties
Technical inquiry about: 3D-UAA04166 17β-Benzoyloxy-androsta-1,4-dien-3-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
